المقدمة
From Clinical Trials to RWE in PsO, PsA and RA
الأهداف
•Present current scientific evidence, including clinical trials, Real-world data, and illustrative case studies, on the management of PsO, PsA and RA.
•Communicate Ixekizumab and Baricitinib value proposition to highlight what the product may mean to people living with Plaque Psoriasis (PsO), Psoriatic Arthritis (PsA) & Rheumatoid Arthritis (RA) respectively.
المستهدفين :
Physician
( Dermatology , Rheumatology )
Resident / Fellow
( Dermatology , Rheumatology )
Pharmacy
المتحدثين
السعر
مجانا
سعر الفعالية
مجانا
الأربعاء 15 أكتوبر 2025 الى الأربعاء 15 أكتوبر 2025 
09:30 مساءاً الى 10:45 مساءاً
الشهادة متاحة 
اونلاين 
